|
|
.
See Category: Diseases of the nervous system
See Header: Absence epileptic syndrome, not intractable
ICD-10 (CM) Code and Descriptor
|
G40.A01 |
Absence epileptic syndrome, not intractable, with status epilepticus
|
G40A01 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 27.61%
|
17.85%
|
13.80%
|
9.09%
|
10.10%
|
5.39%
|
4.38%
|
3.03%
|
4.04%
|
1.68%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for G40.A01*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
73
|
73
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
61
|
65
|
|
80053
|
COMPREHEN METABOLIC PANEL |
51
|
51
|
|
97110
|
THERAPEUTIC EXERCISES |
48
|
90
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
45
|
75
|
|
83735
|
ASSAY OF MAGNESIUM |
42
|
52
|
|
97530
|
THERAPEUTIC ACTIVITIES |
38
|
71
|
|
80048
|
METABOLIC PANEL TOTAL CA |
36
|
50
|
|
71045
|
X-RAY EXAM CHEST 1 VIEW |
33
|
38
|
|
J0692
|
CEFEPIME HCL FOR INJECTION |
32
|
240
|
|
J1953
|
LEVETIRACETAM INJECTION |
32
|
3,400
|
|
C9113
|
INJ PANTOPRAZOLE SODIUM, VIA |
30
|
30
|
|
J0360
|
HYDRALAZINE HCL INJECTION |
28
|
78
|
|
C9254
|
INJECTION, LACOSAMIDE |
24
|
8,400
|
|
84100
|
ASSAY OF PHOSPHORUS |
23
|
23
|
|
J0295
|
AMPICILLIN SULBACTAM 1.5 GM |
20
|
108
|
|
85027
|
COMPLETE CBC AUTOMATED |
19
|
19
|
|
80177
|
DRUG SCRN QUAN LEVETIRACETAM |
19
|
19
|
|
J7030
|
NORMAL SALINE SOLUTION INFUS |
18
|
25
|
|
J2560
|
PHENOBARBITAL SODIUM INJ |
18
|
62
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
G40.A01 related to the following DRG Codes:
023
100-101
|
